Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#1096 How Manage Multiple Small Bowel Neuroendocrine Tumors?
Introduction: Multiple small bowel neuroendocrine tumors (SB-NET) represent 30% of SB-NET.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Pasquet A
Authors: Pasquer A, Walter T, Hervieu V, Forestier J, Scoazec J,
Keywords: small bowel, surgery, prognosis, multiple,
Introduction: Thyrocalcitonin (TCT) is usually associated with medullary thyroid cancer. However, some neuroendocrine tumors (NETs) have also high serum TCT levels.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Nozière C, Chardon L, Lombard-Bohas C, Goichot B, Hervieu V,
Keywords: thyrocalcitonin,
Introduction: Alkylating agents are the backbone chemotherapy in neuroendocrine tumors (NET). However, gemcitabine associated to oxaliplatine (gemox) has showed interesting activity in a small study.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Dussol A, Joly M, Hervieu V, Forestier J, Lombard-Bohas C,
Keywords: gemox, alkylating agent, MGMT,
Introduction: Several systemic treatments are available for metastatic neuroendocrine Tumors (NETs), including everolimus, but there is no predictive factor of response to these treatments.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Walter T
Authors: Benslama N, Bollard J, Vercherat C, Roche C, Hervieu V,
Keywords: neuroendocrine tumors, everolimus, markers, p-p70S6K,
Introduction: Low O6-methylguanine-DNA methyltransferase (MGMT) expression is predictive of response to alkylants in some tumor types.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author:
Authors: Van Brakel B, Walter T, Hervieu V, Forestier J, Chayvialle J,
Keywords: MGMT,